Pharming Group N.V.
PHAR
$11.72
-$0.63-5.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -8.20M | -8.20M |
| Total Depreciation and Amortization | -- | -- | -- | 9.85M | 9.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | 852.00K | 852.00K |
| Total Other Non-Cash Items | -- | -- | -- | 28.26M | 32.00M |
| Change in Net Operating Assets | -- | -- | -- | 290.00K | -3.45M |
| Cash from Operations | -- | -- | -- | 31.05M | 31.05M |
| Capital Expenditure | -- | -- | -- | -906.00K | -906.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -57.48M | -57.48M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 79.59M | 79.59M |
| Cash from Investing | -- | -- | -- | 21.21M | 21.21M |
| Total Debt Issued | -- | -- | -- | -263.00K | -263.00K |
| Total Debt Repaid | -- | -- | -- | -4.28M | -4.28M |
| Issuance of Common Stock | -- | -- | -- | 3.40M | 3.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -11.98M | -11.98M |
| Cash from Financing | -- | -- | -- | -13.11M | -13.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 5.81M | 5.81M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 44.95M | 44.95M |